Bristol-Myers Squibb Company

New York Stock Exchange
Back to all articles
Somewhat Bearish -25

Bristol-Myers Squibb on Pace for Largest Percent Decrease Since November 2025 — Data Talk

AI-generated analysis

📉 Bristol-Myers Squibb (BMY) shares fell 3.78% to $58.30, marking the largest percentage decrease since November 2025.

⏳ The stock is currently down for four of the past six trading sessions.

📅 This week represents BMY's worst weekly performance since late April 2026 when it fell 2.43%.

📉 Shares are down approximately 28% from their all-time closing high reached in December 2022.

⬆️ Despite recent weakness, the stock remains up over 15% compared to its price a year ago.

⬇️ The current price sits below its 52-week high of $62.37 and above its 52-week low of $42.60.

⚠️ Intraday drops hit 4.23%, the largest percentage decline observed since April 2026.

🏆 BMY was among the worst performers in the S&P 500 today, ranking fifth on the list.

📰 The data report originates from Dow Jones and is timestamped May 1, 2026.

⚠️ Morningstar includes a standard disclaimer that third-party content is not verified or endorsed.

❗ Investors are advised to seek independent financial advice before making decisions based on this market data.

🎯 The report concludes coverage of the markets and weekly wrap-up topics including energy stocks and IPO questions.

Bullish Signals
  • The stock remains up 15.29% from 52 weeks ago (May 2, 2025), when it closed at $50.57, demonstrating long-term value.
  • Bristol-Myers Squibb is up 36.85% from its 52-week closing low of $42.60 on Oct. 29, 2025, indicating significant recovery potential.
Risk Factors
  • Bristol-Myers Squibb (BMY) is currently at $58.30, marking a 28.14% decline from its all-time high of $81.13 reached on Dec. 2, 2022.
  • The stock is down 6.53% from its 52-week closing high of $62.37 recorded on Feb. 27, 2026, indicating sustained pressure below recent peaks.
  • BMY has been down four of the past six trading days, with the current intraday drop of 4.23% being the largest since April 2, 2026.
  • The stock ranks as the fifth worst performer in the S&P 500 for the current session, highlighting significant relative weakness compared to peers.
  • This price decline follows the company's status as being on pace for its largest percent decrease since November 14, 2025.
Full Analysis
Bristol-Myers Squibb (BMY) shares are trading at $58.30, reflecting a decline of $2.29 or 3.78% as of May 1, 2026. The company is currently on pace for its largest percentage decrease since November 14, 2025, when the stock fell 4.07%. This latest drop marks the fourth consecutive day of losses for the stock and contributes to a week characterized by poor performance, with shares down 0.70%. Notably, this weekly decline represents the worst performance since the week ending April 24, 2026, when BMY fell 2.43%. In terms of longer-term trends, Bristol-Myers Squibb's current price is down 28.14% from its all-time closing high of $81.13 on December 2, 2022. Despite the recent decline, the stock remains up 15.29% from its closing price one year ago, which was $50.57 on May 2, 2025. The shares are also down 6.53% from its 52-week closing high of $62.37 set on February 27, 2026, but remain up 36.85% from its 52-week low of $42.60 reached on October 29, 2025. The intraday trading saw shares drop an additional 4.23% at their lowest point today, marking the largest single-day intraday decrease since April 2, 2026. Consequently, BMY ranks as the fifth worst performer within the S&P 500 for the day.